"Research of the Application of Pancreatic Cancer Screening Artificial Intelligence Model PANDA PLUS"

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,000,000

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

October 31, 2026

Conditions
Pancreatic Cancer
Interventions
DEVICE

PANDA PLUS

Using the PANDA PLUS model to assist in image interpretation, radiologists are provided with the model's output classification-non-PDAC, PDAC, or normal-alongside the initial CT image assessment. The radiologists then integrate the information from both the PANDA PLUS output and the original image interpretation to formulate the final report.

Trial Locations (1)

310000

the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
collaborator

Lishui Municipal Central Hospital

OTHER_GOV

collaborator

Second Affiliated Hospital of Nanchang University

OTHER

lead

Zhejiang University

OTHER

NCT06643715 - "Research of the Application of Pancreatic Cancer Screening Artificial Intelligence Model PANDA PLUS" | Biotech Hunter | Biotech Hunter